Unlock Your Share of $100B in Non-Dilutive Capital

Join us for this exclusive event to discover how innovative companies can tap into the $100 billion of non-dilutive funding available each year. Gain expert insight from Dr. Eva Garland as she guides you through the complex U.S. funding landscape, covering hundreds of government programs as well as private foundation grants. Plus, hear from Stanley Kim on how WinSanTor secured over $20 million in non-dilutive funding to drive cutting-edge advancements. 

Date

June 25, 2025 | 3:30 PM to 7 PM

Location

The Cove @ UCI, 5270 California Ave. Irvine, CA 92617

Register

Agenda

  • 3:30 PM – Welcome
    Check in and connect with fellow attendees.
  • 4:00 PM – Presentation by Dr. Eva Garland with Special Guest, Stanley Kim
    Gain expert insights from Dr. Eva Garland as she guides you through integrating non-dilutive funding into a comprehensive financing strategy. Plus, hear from Stanley Kim on how WinSanTor secured over $20 million in non-dilutive funding to drive cutting-edge advancements.
  • 5:00 to 7:00 PM – Cocktail Reception
    Enjoy drinks and hors d’oeuvres as you mingle with distinguished guests.

In this Seminar:

  • Discover Over $100 Billion in Annual Non-Dilutive Funding Opportunities: Gain a comprehensive understanding of the vast landscape of non-dilutive funding available to innovative companies, including programs from the NIH, ARPA-H, BARDA, and DoD. 
  • Integrate Non-Dilutive Funding into a Comprehensive Financing Strategy: Learn how non-dilutive sources can complement traditional equity-based funding, resulting in a greater probability of success as well as higher ROI and valuations at exit. 
  • Gain Practical Insights from a Successful Case Study: Hear from WinSanTor CEO Stanley Kim on how WinSanTor secured over $20 million in non-dilutive funding to advance treatments for peripheral neuropathy, providing a real-world example of leveraging non-dilutive sources to move from pre-clinical to clinical development. 

About the speakers:

Dr. Eva Garland, CEO, Eva Garland Consulting

Dr. Eva Garland is the founder and CEO of Eva Garland Consulting (EGC), a nationally recognized leader in securing non-dilutive funding. With offices in Raleigh, North Carolina and Irvine, California, EGC’s team of Ph.D. Scientific Grants Experts and accounting professionals have supported over 3,000 companies in successfully winning over $2 billion in critical non-dilutive funding. EGC’s expert team has helped our clients ranging from early-stage companies to multi-national large pharma obtain grants, from $100K to $100M, that bridge the “valley of death” and advance innovative technologies through the rigorous research & development process.

Stanley Kim, CEO & Founder, WinSanTor

Stanley Kim is a seasoned entrepreneur and the founder of companies across various tech industries, including pharmaceutical/biotechnology, medical device, and software. He is currently CEO and Founder of WinSanTor, a company that has successfully discovered and developed the first disease-modifying therapeutic for peripheral neuropathy. WinSanTor has benefited from over $20 million in non-dilutive funding to advance pre-clinical and clinical development of their leading therapy.

Join University Lab Partners for a Pitch Practice Event before the Seminar from 2 PM – 4 PM.

Click here to learn more.

“I have worked with Eva Garland over multiple grant applications and always had a stellar experience. Not only do they help as general writers but also perform great research and ask the hard questions required to make our applications really stand out.”

Grant Chapman, CEO

Glassboard

“I’ve worked with Eva Garland Consulting for nearly a decade, and throughout that time, they have consistently met, and often exceeded, all of my expectations. As a small startup operating in a highly technical and competitive space, we have relied on their guidance to help us navigate everything from complex SBIR/STTR compliance and accounting to strategic planning and funding advisement.”

Anthony Dellinger

Kepley BioSystems

“Our decision to work with Eva Garland was an excellent decision. They know what information the grant reviewers want to see, so were able to provide us with very helpful guidance that made our proposal far more persuasive.”

Brinton Baker, VP of Global Marketing

dFarm

“I wanted to share our experience with the team so far. We are super impressed with their work and really enjoy working with EGC’s consultants! They are lovely and super talented.”

David Nason, CEO

HireBrain

“I would strongly recommend working with EGC for grant writing. They are very knowledgeable, professional, and easy to work with. I started working with them as a recipient of the NIH AAP program, but I have now continued seeking their help for all my grant writing, even if it is just to get a second pair of eyes on my submission package.”

Nordine Sebkhi, CEO

Kinemo, Inc.

“I have had an excellent experience working with the team at Eva Garland consulting. Would highly recommend them!”

Richard Horowitz, Medical Director

Medical Director, MSIDS Research Foundation, Inc.